Stocks and Investing
Stocks and Investing
Fri, December 3, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Greg Harrison Initiated (STOK) at Strong Buy and Held Target at $43 on, Dec 3rd, 2021
Greg Harrison of B of A Securities, Initiated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $43 on, Dec 3rd, 2021.
Greg has made no other calls on STOK in the last 4 months.
There is 1 other peer that has a rating on STOK. Out of the 1 peers that are also analyzing STOK, 0 agree with Greg's Rating of Hold.
This is the rating of the analyst that currently disagrees with Greg
- Jessica Fye of "JP Morgan" Upgraded from Hold to Buy and Held Target at $41 on, Monday, November 22nd, 2021
Contributing Sources